The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.

Using the breast carcinoma cell line MDA-MB 468 as immunogen, we have produced six new rat monoclonal antibodies (mAbs) against the human EGF receptor (EGFR) and are investigating their use for diagnostic and therapeutic applications in cancer patients whose tumours overexpress these receptors. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Modjtahedi, H., Styles, J. M., Dean, C. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968163/
https://www.ncbi.nlm.nih.gov/pubmed/8094290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968163/
https://www.ncbi.nlm.nih.gov/pubmed/8094290

Ejemplares similares